The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

Eli Lilly briefly crossed the $1 trillion market cap threshold, the first drug maker to ever reach that milestone.

Wall Street projects the global weight-loss drug market could reach $150 billion by 2030, with Lilly and Novo Nordisk ...

The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Separately, companies, including digital health firm Waltz Health and cardiometabolic care provider 9amHealth announced ...

Eli Lilly hit a $1 trillion valuation, driven by demand for Zepbound and Mounjaro. The first health-care firm ever to join ...

Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo ...

Eli Lilly has broken free from the Big Pharma pack. Fueled by sky-high expectations for the GLP-1 market, Lilly has achieved ...

Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This ...

Eli Lilly’s stock checks all the boxes for a split. the price keeps climbing, the company is on fire, and it’s a bull market.